Treatment of canine cognitive dysfunction with novel butyrylcholinesterase inhibitor

Canine cognitive dysfunction (CCD) is common in aged dogs and has many similarities with Alzheimer’s disease. Unfortunately, like Alzheimer’s disease, CCD cannot be cured. In the present study, we treated dogs with CCD with our newly developed and characterized butyrylcholinesterase inhibitor (BChEi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zakošek Pipan, Maja, Prpar Mihevc, Sonja, Štrbenc, Malan, Košak, Urban, German Ilić, Ilija, Trontelj, Jurij, Žakelj, Simon, Gobec, Stanislav, Pavlin, Darja, Majdič, Gregor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438013/
https://www.ncbi.nlm.nih.gov/pubmed/34518582
http://dx.doi.org/10.1038/s41598-021-97404-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438013/
https://www.ncbi.nlm.nih.gov/pubmed/34518582
http://dx.doi.org/10.1038/s41598-021-97404-2

Ejemplares similares